INTRODUCTION
Rheumatoid arthritis (RA) is an autoimmune rheumatic disease in which chronic inflammation is associated with pathology of the peripheral joints. RA is characterized by synovial joint inflammation and the overgrowth of synoviocytes leading to cartilage and bone destruction. CD4+ T cells are currently assumed to be the prime mediators of synovitis and the involvement of a number of cytokines in virtually all stages of rheumatoid joint inflammation, cartilage destruction and bone remodeling has been shown (1).
TNF-α and IL-10 have opposing roles in inflammatory responses. TNF-α is a key pro-_________________________ inflammatory cytokine in RA pathogenesis (2). It induces tissue-specific signal transduction leading to gene expression of other cytokines such as IL-1, IL-6and L-8, involved in the pathogenic process (3). IL-10 is an immunoregulatory cytokine that is produced by almost all cells of the innate and adaptive immunity (4). Although IL-10 is associated with Th2 responses, it is important for T cell regulatory functions. There is an autoregulatory feedback loop -TNF-α induces the production of IL-10, which in turn reduces the TNF-α synthesis (5).
TNF-α and IL-10 can be regulated at the transcriptional level and a numbers of genetic polymorphisms in the regulatory regions of TNFA and IL10 genes are associated with changes in gene expression (6, 7). Among the common single nucleotide polymorphisms (SNPs), a G to A transition at position -308 in the promoter of TNFA (rs1800629) and A to G transition at position -1082 of IL10 gene (rs1800896) have been the most widely analyzed. Until now, several studies have examined the association of IL10 rs1800896 and TNFA rs1800629 polymorphisms with susceptibility to RA in different populations (8) (9) (10) . However, the results in the literature in this respect are unconvincing. In the present study, we aimed to investigate the influence of functional IL10 -1082G/A and TNFA -308G/A promoter polymorphisms and of the combined genotypes in these loci on the susceptibility to rheumatoid arthritis (RA) in Bulgarian population.
MATERIALS AND METHODS

Subjects
A total of 135 patients with RA referred to Rheumatology Clinic of St Iv Rilski University Hospital in Sofia were included in this crosssectional study and compared with 179 healthy subjects. All patients fulfilled the American College of Rheumatology classification criteria for RA (11) . The group of RA patients consisted of 11 (8.1%) males and 124 (91.9%) females from 14 to 77 years old with a mean (± SD) age of 45.8 ± 13.2 years. The mean (±SD) disease duration of RA patients was 9.5 ± 7.9 years (range 1-40). The sex and age distribution of the healthy controls (HC) was: 15 (8.4%) males and 164 (91.6%) females; aged 41.5±13.96. years, range 20-84 years. This study was approved by the institutional ethics committee and all subjects signed an informed consent.
Genetic analysis
Genomic DNA was extracted from peripheral whole blood using the NucleoSpin Blood L Purification kit (Macherey-Nagel, Duren, Germany) and stored at -80°C until use.
Genotyping for the −1082A/G SNP in IL10 (rs1800896) was performed by amplification refractory mutation system (ARMS)-PCR, using forward primer specific for G allele 5′-CCTATCCCTACTTCCCCC-3′, forward primer specific for A allele 5′-CCTATCCCTACTTCCCCT-3′ and reverse primer generic for IL10 5′AGCAACCACTCCTCGTCGCAAC-3′. PCR amplification was performed in a GeneAmp PCR System 9700 (Applied Biosystems) as described by Stanilova et al. (12) . PCR products were visualized on a 2 % agarose gel stained with ethidium bromide (0.5 mg/ml).
Genotyping for the -308G/A polymorphism in the TNFA gene (rs1800629) was performed by restriction fragment length polymorphisms (RFLP) analysis of PCR fragment amplified using the modified forward primer 5-AGG CAA TAG GTT TTG AGG GCC AT 3 and the reverse primer 5-TTG GGG ACA CAC AAG CAT CAA GG 3 to create a restriction site for the NcoI enzyme as described by Manolova et al. (13) . Restriction enzyme of Nco1 (Thermo Scientific) digestion with the PCR product was carried out overnight at 37°C and then analyzed on a 3% agarose gel. DNA products were visualized by ethidium bromide staining. Sizes of restriction fragments were 150bp for -308 A allele and 128, 22bps for -308 G allele.
Statistical analysis.
All data for this study were analyzed using the software SPSS version 16.0 for Windows (SPSS Inc., Chicago, IL). The differences in genotype distribution and allele frequency among cases and controls were analyzed using the χ2 test. Odd ratios with 95 % confidence interval was determined to describe the strength of association by logistic regression model. The goodness of fit to Hardy-Weinberg equilibrium, calculating the expected frequencies of each genotype and comparing them with the observed values for patients and healthy controls, was performed using a  2 test. In all cases, two-tailed p-values less than 0.05 were considered as significant.
RESULTS
The genotype distribution and allele frequencies of -308G/A in gene promoter of TNFA among cases and controls are presented in Table 1 . The genotype frequencies were following Hardy-Weinberg equilibrium among cases (p = 0.723) and controls (p = 0.957). The distribution of TNFA -308 genotypes and allele frequencies were quite similar between cases and controls.
The genotype distribution and allele frequencies of -1082A/G in gene promoter of IL10 among healthy controls and RA cases are presented in association of TNFA alleles and susceptibility to RA in Dutch ethnicity. In Spanish and French patients, no association of TNFA promoter variation at position -308 with RA susceptibility has been detected (8, 14) . However, unlike the Caucasian, in a large cohort of Japanese patients with RA (n=545) an increase of -308G allele was established, which was associated with HLA-DRB1*0405 (9) . Another study with a non-Caucasian population from Taiwan (15) also showed an increased frequency of the -308G allele in RA patients. It could be considered that the -308G/A SNP may have a different effect on the genetic predisposition to RA development, depending on the race. In this regard, our results are in agreement with these observations, as Bulgarians belong to Caucasians.
Conflicting results were also reported regarding the possible association between IL10 -1082 A/G polymorphism and RA susceptibility in the different populations. These differences point to the importance of doing studies in the separate ethnic groups. Some works showed significant associations between IL10 -1082A/G SNP with RA susceptibility or with the development of certain clinical features (16) (17) (18) (19) , while other studies indicated that these polymorphisms did not appear to have any relevance in the disease (20, 21) . The associations between IL-10 polymorphisms and susceptibility to RA has been recently reviewed by Lee et al. in a metaanalysis of the polymorphisms in IL-10 gene (10) . This meta-analysis reveals that the -1082G allele in four studies in HWE showed a significant association with RA appearance with OR of 1. 217. Our results are in the same direction. We found that the presence of the IL10 -1082 allele G in the genotype could be a risk factor for RA in Bulgarian population. In addition, individuals who carried the combined high-producing genotypes of IL10 (-1082GG) and TNFA (-308AA/AG) had a 5 times increased genetic risk for the development of RA.
With regard to IL-10 and TNF-alpha genegene interaction, Suarez et al. reported that subjects carrying the IL10 rs800896 GG and TNFA rs rs1800629 AA/AG genotypes had a 3.87-fold elevated risk of developing systemic lupus erythematosus (22) , an observation similar to our results. Although the molecular mechanism is not entirely clear, the IL10 -1082GG/TNFA-308A carriers may have high protein production, due to higher transcriptional activity ( 6, 23). Higher production of both pro-inflammatory TNF-α and anti-inflammatory IL-10, may lead to cytokine network disturbance and predisposition to autoimmunity.
In conclusion, our results demonstrate the week association of promoter polymorphism -1082 A/G in the IL-10 gene, but not of the TNFA -308G/A polymorphic variants with genetic predisposition to rheumatoid arthritis in Bulgarian population. Moreover, subjects carrying the IL-10 rs1800896GG and TNFA -308AA/GA genotypes had a 4.95-fold increased risk of RA development.
The combined genotypes in IL10/TNFA significantly influence RA susceptibility, proving the existence of a genetic predisposition to abnormal immune regulation in this chronic inflammatory joint disease. 
ACKNOWLEDGMENTS
